89bio
Developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic diseases
123 employees · est. 2018 · San Francisco, United States
Synta Pharmaceuticals
Innovating patient care with advanced small molecule therapies for severe medical conditions, including cancer and chronic inflammatory diseases.
est. 2000
Synta Pharmaceuticals is the older company (2018 vs 2000).
Side-by-Side Comparison
| Metric | 89bio | Synta Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2000 older |
| Headquarters | ||
| Headquarters | San Francisco, United States | Not tracked yet |
| Employees | ||
| Employees | 123 | Not tracked yet |
| Industry | ||
| Industry | Biopharma, Biotechnology, Pharmaceutical | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $773.20M | $217.35M |
| Funding Rounds | ||
| Funding Rounds | 7 | 8 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Clinical-stage, FGF21 Analog, NASH Treatment, SHTG Treatment, Liver Diseases, Cardio-metabolic Diseases, Innovative Therapies, Phase 2 Trial, Patient-centric, Ethical Standards, Scientific Advancement, San Francisco, Herzliya, Israel | Biopharmaceutical Company, Small Molecule Drugs, Cancer Treatment, Chronic Inflammatory Diseases, Drug Discovery, Clinical Development, Global Partnership, Roche Collaboration, Lead Optimization, Autoimmune Diseases, Hsp90 Inhibitor, Rheumatoid Arthritis, Medical Innovations |
| Website | ||
| Website | 89bio.com | syntapharma.com |
About 89bio
89bio 89bio is a clinical-stage biopharmaceutical company with a focus on developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic diseases. Their lead product candidate, BIO89-100, is an engineered glycoPEGylated analog of FGF21 designed for the treatment...
About Synta Pharmaceuticals
Synta Pharmaceuticals is a biopharmaceutical company founded in 2000, with a focus on discovering, developing, and commercializing small molecule drugs to improve the lives of patients with severe medical conditions such as cancer and chronic inflammatory diseases. The company has a global partnersh...
We will tell you when either one moves
BounceWatch watches 89bio and Synta Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at 89bio and Synta Pharmaceuticals — by email.
Frequently Asked Questions
Compare 89bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at 89bio on 9 Jun 2026, and Synta Pharmaceuticals on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.